Complications of allergic rhinitis

Slides:

Advertisements

Similar presentations

Copyright © 1999 American Medical Association. All rights reserved.

Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria

Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis Fuad M. Baroody, MD, David Brown, MD,

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses Stephen R. Durham,

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study Eli O. Meltzer, MD, Paul.

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials Javier Dibildox,

A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis William R. Lumry, MD Journal of.

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses Stephen R. Durham,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Fluticasone furoate nasal spray reduces the nasal-ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms

Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial Jens U. Ponikau, MD, David.

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Is 9 more than 2 also in allergic airway inflammation?

Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials Javier Dibildox,

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Practice Notes from the AAAI

T lymphocytes in asthma: Bronchial versus peripheral responses

Practice Notes from the AAAAI

Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy–induced asthma Simi Kapoor, MD, Shyam A. Patel, PhD,

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,

Oral phenylephrine: An ineffective replacement for pseudoephedrine?

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults Christian Lupinek, MD,

Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis Fuad M. Baroody, MD, David Brown, MD,

The impact of allergic rhinitis on bronchial asthma

Michael Mellon, MD Journal of Allergy and Clinical Immunology

Practice Notes from the AAAAI

Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic.

Increased sensitivity to bradykinin among African Americans

Reply Journal of Allergy and Clinical Immunology

A review of the current guidelines for allergic rhinitis and asthma

Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge Adriaan.

News & Notes Journal of Allergy and Clinical Immunology

Phillip Lieberman, MD, David Golden, MD

Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial Hendrik.

Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis Robert P. Harvey, MD, Carolyn Comer, MD, Barbara Sanders, MD, Ross Westley,

Autophagy: Nobel Prize 2016 and allergy and asthma research

Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis Thomas B. Casale, MD, William.

News & Notes Journal of Allergy and Clinical Immunology

Philip Fireman, MD Journal of Allergy and Clinical Immunology

Objective monitoring of nasal airway inflammation in rhinitis

The effects of antihistamines on cognition and performance

The role and remediation of animal allergens in allergic diseases

Chemokines in seasonal allergic rhinitis

Bradykinin increases the in vivo expression of the CXC chemokine receptors CXCR1 and CXCR2 in patients with allergic rhinitis Jane Eddleston, PhD, Sandra.

Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes Margerita M. Riccio, PhD, David.

Practice Notes from the AAAI

Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis Carmen Rondón, MD, PhD, Javier.

Corticosteroids in the treatment of pediatric allergic rhinitis

Objective monitoring of nasal patency and nasal physiology in rhinitis

An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment Eli O. Meltzer, MD, Robert B. Berkowitz,

Alvaro A. Cruz, MD, Robert M

Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma Sally E. Wenzel, MD Journal of Allergy and Clinical.

Footnotes1 Journal of Allergy and Clinical Immunology

Update on risk factors for food allergy

Systemic effects of local allergic disease

Effect of grass sublingual tablet immunotherapy is similar in children and adults: A Bayesian approach to design pediatric sublingual immunotherapy trials

Fiftieth Annual Meeting of the American Academy of Allergy and Immunology: Anaheim, California, March 1994 Lawrence M. Lichtenstein, MD, PhD Journal.

Dendritic cells in nasal mucosa of subjects with different allergic sensitizations Susanne M. Reinartz, MD, Joost van Tongeren, MD, Danielle van Egmond,

The correlation between allergic rhinitis and sleep disturbance

News & Notes Journal of Allergy and Clinical Immunology

Amb a 1–immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response Meri K Tulic, PhD, Pierre-Olivier Fiset,

Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease Jaclyn Smith, MD, PhD, Emily Owen, MPhil, John Earis, MD,

An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment Eli O. Meltzer, MD, Robert B. Berkowitz,

Unique mechanistic features of allergic rhinitis

Presentation transcript:

Complications of allergic rhinitis David P Skoner, MD Journal of Allergy and Clinical Immunology Volume 105, Issue 6, Pages S605-S609 (June 2000) DOI: 10.1067/mai.2000.106150

Fig. 1 . Nasal allergy and chronic OME in various pediatric populations. *Control group. (Adapted from Tomonaga K, Kurono Y, Mogi G. The role of nasal allergy in otitis media with effusion. Acta Otolaryngol [Stockh] 1988;458[suppl]:41-7. With permission.) Journal of Allergy and Clinical Immunology 2000 105, S605-S609DOI: (10.1067/mai.2000.106150)

Fig. 2 . Changes in environment (A ) pollen and (B ) eustachian tube obstruction before (week 1), during (weeks 2 to 9), and after (weeks 10 and 11) grass pollen season. *P < .05 versus baseline. (Modified with permission from Skoner DP, Lee L, Doyle WJ, Boehn S, Fireman P. Nasal physiology and inflammatory mediators during natural pollen exposure. Ann Allergy 1990;65:206-10. Copyright ACAAI.) Journal of Allergy and Clinical Immunology 2000 105, S605-S609DOI: (10.1067/mai.2000.106150)

Fig. 3 . The distribution of nasal- and eustachian tube–obstructing antigen doses for study subjects. Open bar , nasal obstruction; filled bar , eustachian tube obstruction.(Adapted from Skoner DP, Doyle WJ, Chamovitz AH, Fireman P. Eustachian tube obstruction after intranasal challenge with house dust mite. Arch Otolaryngol Head Neck Surg 1986;112:840-2. Copyright 1986, American Medical Association.) Journal of Allergy and Clinical Immunology 2000 105, S605-S609DOI: (10.1067/mai.2000.106150)

Fig. 4 . Incidence of eustachian tube obstruction in patients who were sensitized to ragweed and who were challenged with antigen after pretreatment with either placebo or antihistamine plus decongestant. (Modified with permission from Stillwagon PK, Doyle WJ, Fireman P. Effect of an antihistamine/decongestant on nasal and eustachian tube function following intranasal pollen challenge. Ann Allergy 1987;58:442-6. Copyright ACAAI.). Journal of Allergy and Clinical Immunology 2000 105, S605-S609DOI: (10.1067/mai.2000.106150)